|
Volumn 138, Issue 1, 2012, Pages 10-11
|
Immunohistochemistry cocktails are here to stay: Center for Medicare and Medicaid Services should revise its new reimbursement policy
a a a a a a a a a a a a a a a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CD20 ANTIGEN;
KERATIN;
KERATIN ANTIBODY;
KI 67 ANTIGEN;
CELL PROLIFERATION;
DIAGNOSTIC ACCURACY;
DISEASE MARKER;
EDITORIAL;
FLOW CYTOMETRY;
HEALTH CARE POLICY;
HEALTH CARE QUALITY;
HEALTH CARE UTILIZATION;
HISTOPATHOLOGY;
IMMUNOHISTOCHEMISTRY;
MEDICAID;
MEDICARE;
NEEDLE BIOPSY;
PHYSICIAN;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
PROFESSIONAL KNOWLEDGE;
REIMBURSEMENT;
REPRODUCIBILITY;
UROLOGIST;
CENTERS FOR MEDICARE AND MEDICAID SERVICES (U.S.);
HUMANS;
IMMUNOHISTOCHEMISTRY;
MEDICAID;
MEDICARE;
REIMBURSEMENT MECHANISMS;
UNITED STATES;
|
EID: 84864211038
PISSN: 00029173
EISSN: 19437722
Source Type: Journal
DOI: 10.1309/AJCPCGFDF4ECG8QN Document Type: Editorial |
Times cited : (5)
|
References (1)
|